Holland-Frei Cancer MedicineRobert C. Bast, Jr., Carlo M. Croce, William N. Hait, Waun Ki Hong, Donald W. Kufe, Martine Piccart-Gebhart, Raphael E. Pollock, Ralph R. Weichselbaum, Hongyang Wang, James F. Holland John Wiley & Sons, 13 մրտ, 2017 թ. - 2008 էջ Holland-Frei Cancer Medicine, Ninth Edition, offers a balanced view of the most current knowledge of cancer science and clinical oncology practice. This all-new edition is the consummate reference source for medical oncologists, radiation oncologists, internists, surgical oncologists, and others who treat cancer patients.
|
Բովանդակություն
Principles of psychooncology | |
Monoclonal serotherapy | |
Urothelial cancer | |
Cover | |
Drug interactions | |
Dedication | |
List of contributors | |
Preface | |
Hematopoietic cell transplantation | |
Principles of pediatric oncology | |
Cancer and pregnancy | |
Systemic therapy | |
Psychosocial issues | |
Cancer and aging | |
Neoplasms in acquired immunodeficiency | |
Cancer survivorship new challenge in cancer | |
Cancer genomelandscapes | |
Biological hallmarks of cancer | |
References | |
Molecular biology genomics proteomics | |
General techniques | |
Oncogenes | |
Disease Sites | |
Epidemiology Prevention and Detection | |
Tumor suppressor genes | |
Epigenetic contributions to human cancer | |
Management of Cancer Complications | |
MicroRNA expression in cancer | |
Aberrant signaling pathways in cancer | |
Growth factor signaling and cancer therapy | |
References | |
Differentiation therapy | |
References | |
Cancer stem cells | |
Cancer and cell death | |
List of abbreviations | |
Cancer cell immortality targeting telomerase | |
Cancer metabolism | |
Modeling therapy of late or earlystage | |
Acknowledgments | |
of genomic medicine | |
Burnout in oncology | |
Chemical carcinogenesis | |
chemical carcinogenesis | |
References | |
Endocrine and genetic bases of hormonerelated | |
Ionizing radiation | |
Neoplasms of the esophagus | |
Ultraviolet radiation carcinogenesis | |
Inflammation and cancer | |
RNA tumor viruses | |
Herpesviruses | |
Papillomaviruses and cervical neoplasia | |
Hepatitis viruses and hepatoma | |
Parasites | |
Chemoprevention of cancer | |
Nexgen pathology predicting clinical course | |
Molecular diagnostics in cancer | |
Systems biology and genomics | |
Risk behaviors for skin cancer | |
Principles of imaging | |
Interventional radiology for the cancer patient | |
Principles of surgical oncology | |
cancer patient | |
Principles of radiation oncology | |
Principles of medical oncology | |
Palliative care and pain management | |
Principles of cancer rehabilitation medicine | |
Integrative oncology in cancer care | |
Health services research | |
Personalized medicine in oncology drug | |
Preclinical and early clinical development | |
Tumor growth kinetics | |
Etiology | |
Folate antagonists | |
References | |
Pyrimidine and purine antimetabolites | |
Guanine antimetabolites | |
Alkylating agents and platinum antitumor | |
Administration dose and schedule | |
Clinical pharmacology | |
Other natural products that enhance tubulin | |
Drug resistance and its clinical circumvention | |
overcome drug resistance | |
Cytokines interferons and hematopoietic | |
Acknowledgment | |
Vaccines and immunostimulants | |
References | |
Cellbased cancer immunotherapy | |
Cancer gene therapy | |
DNA topoisomerase targeting drugs | |
practice? | |
Neoplasms of the | |
Neoplasms of the thyroid | |
Neoplasms of the anus | |
Diagnosis | |
Neoplasms of the adrenal cortex | |
Tumors of the diffuse neuroendocrine | |
Agents targeting microtubules and mitotic | |
Cancer of the lung | |
Malignant pleural mesothelioma | |
Thymomas and thymic tumors | |
Acute lymphoblastic leukemia | |
Principles of dose schedule and combination | |
Tumors of the heart and great vessels | |
References | |
Primary germ cell tumors of the thorax | |
Carcinoma of the stomach | |
Diagnosis | |
Primary neoplasms of the liver | |
Epithelioid hemangioendothelioma | |
Gallbladder and bile duct cancer | |
Neoplasms of the exocrine pancreas | |
Neoplasms of the small intestine vermiform | |
Renal cell carcinoma | |
Neoplasms of the prostate | |
Tumors of the penis and the urethra | |
Tumor staging | |
Pelvic lymphadenectomy | |
Prognosis | |
Testis cancer | |
Staging | |
Neoplasms of the vulva and vagina | |
Treatment | |
Neoplasms of the cervix | |
Endometrial cancer | |
Nonepithelial ovarian malignancies | |
Molar pregnancy and gestational trophoblastic | |
Subsequent pregnancies | |
Neoplasms of the breast | |
Other skin cancers | |
References | |
Bone tumors | |
Soft tissue sarcomas | |
Chronic myeloid leukemia | |
Gynecologic sarcomas | |
Pathology | |
Chronic lymphocytic leukemia | |
Malignant melanoma | |
Treatment of recurrent disease | |
Hospice | |
Hodgkin lymphoma | |
The myelodysplastic syndrome | |
NonHodgkins lymphoma | |
Mycosis fungoides and Sézary syndrome | |
Plasma cell tumors | |
Myeloproliferative neoplasms essential | |
Antiemetic therapy | |
References | |
Neurologic complications of cancer | |
Dermatologic complications of cancer | |
Disparities in cancer care | |
Hematologic complications and blood bank | |
Coagulopathic complications of cancer patients | |
Urologic complications | |
Cardiac complications | |
Respiratory complications | |
Gastrointestinal and hepatic complications | |
Oral complications of cancer and their | |
Gonadal complications | |
Endocrine complications and paraneoplastic | |
production | |
Infections in patients with cancer | |
and humoral immunity | |
A vision for twentyfirst century healthcare | |
Scaling | |
References | |
Epithelial ovarian fallopian tube | |
Այլ խմբագրություններ - View all
Common terms and phrases
abnormalities Acad Sci USA acid activation allele alterations amplification analysis Anderson Cancer Center antibody apoptosis associated BRAF BRCA1 breast cancer cancer cells Cancer Center Houston Cancer Genome Cancer Res carcinoma cDNA cellular Chapter chromosome Clin clinical cloning colorectal cancer cytogenetic deletions Deregulated detection disease DNA methylation drugs encodes enzyme epigenetic exon Figure fragments function fusion gene expression genome growth factor hallmark human cancer hybridization identified imatinib inactivation inhibitors involving KRAS lung cancer lymphoma malignant MD Anderson Cancer Medicine melanoma metastatic microRNA miRNAs molecular molecules mRNA Nat Genet Natl Acad Sci neoplasms normal nucleotide oncogenes Oncol Oncology ovarian cancer pathways patients phenotype phosphorylation plasmid polymerase Proc Natl Acad Professor protein proto-oncogene rearrangements receptor regulation retinoblastoma sarcoma sequencing signaling somatic mutations Southern blotting specific studies syndrome Table target Texas MD Anderson therapeutic therapy tissue translocation tumor suppressor genes tumorigenesis TX USA tyrosine kinase University of Texas Wilms